Company Search:
Advanced Search
Sponsored Links
GlaxoSmithkline Consumer Nig PLC Company Snapshot
GlaxoSmithkline Consumer Nig PLC operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithkline Consumer Nig PLC with three other pharmaceutical manufacturers in Africa: Promopharm SA of Morocco (2015 sales of 532.84 million Moroccan Dirhams [US$54.08 million] ), Societe Adwya SA of Tunisia (89.02 million Dinar [US$39.65 million] ), and Societe De Therapeutique Marocaine which is based in Morocco (1.16 billion Moroccan Dirhams [US$117.28 million] of which 100% was Drug Manufactures).

Sales Analysis. During the year ended December of 2015, sales at GlaxoSmithkline Consumer Nig PLC were 30.63 billion Naira (US$100.48 million). This is a very small increase of 0.4% versus 2014, when the company's sales were 30.52 billion Naira. This was the fifth consecutive year of sales increases at GlaxoSmithkline Consumer Nig PLC (and since 2010, sales have increased a total of 82%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
GlaxoSmithkline Consumer Nig PLC
  Stock Performance Chart for GlaxoSmithkline Consumer Nig PLC
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 18.39
(Figures in Naira)
1 Week -3.2%   13 Weeks -6.2%  
4 Weeks 1.9%   52 Weeks -50.2%  
GlaxoSmithkline Consumer Nig PLC Key Data:
  Ticker: GLAXOSMITH Country: Nigeria
  Exchanges: NIG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 30,634,708,000
(Year Ending Jan 2016).
Employees: 322
  Currency: Naira Market Cap: 21,992,159,640
  Fiscal Yr Ends: December Shares Outstanding: 1,195,876,000
  Share Type: Closely Held Shares: 444,444,784
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.